Cargando…

COVID-19 vaccination in myasthenia gravis: safe, but predictors of disease exacerbation yet to be determined

Detalles Bibliográficos
Autores principales:	Kim, Sohyeon, Eun, Mi-Yeon, Seok, Hung Youl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938504/ https://www.ncbi.nlm.nih.gov/pubmed/36808584 http://dx.doi.org/10.1007/s10072-023-06694-z

Ejemplares similares

COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation
por: Trinchillo, Assunta, et al.
Publicado: (2022)

Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review
por: Rodrigues, Cleonisio Leite, et al.
Publicado: (2022)

Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD
por: Kim, Sohyeon, et al.
Publicado: (2023)

An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis
por: Wang, H.Y., et al.
Publicado: (2023)

Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis following third dose of BNT162b2 COVID-19 vaccine in a patient with systemic lupus erythematosus
por: Kang, Minsung, et al.
Publicado: (2023)

Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19
por: Scopelliti, Giuseppe, et al.
Publicado: (2020)

Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic
por: Ricciardi, Dario, et al.
Publicado: (2021)

Generalized myasthenia gravis patients infected with COVID-19 should continue eculizumab
por: Mimori, Masahiro, et al.
Publicado: (2022)

The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis
por: Galassi, Giuliana
Publicado: (2022)

New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series
por: Fanella, Gaia, et al.
Publicado: (2022)

Letter response to “The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis”
por: Nóbrega, Paulo Ribeiro, et al.
Publicado: (2022)

Reply to Letter response to “The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis”
por: Galassi, Giuliana, et al.
Publicado: (2022)

A mild course of COVID-19 infection in a generalized Myasthenia gravis patient under eculizumab treatment
por: Alis, Ceren, et al.
Publicado: (2022)

The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis
por: Seok, Hung Youl, et al.
Publicado: (2017)

Isolated COVID-19 Infection Precipitates Myasthenia Gravis Crisis: A Case Report
por: Moschella, Phillip, et al.
Publicado: (2020)

Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study
por: Özdemir, Hüseyin Nezih, et al.
Publicado: (2022)

Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication
por: Cho, Hye-Kyung, et al.
Publicado: (2022)

Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey
por: Noh, Yunha, et al.
Publicado: (2022)

Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic
por: Gundavda, Manit K., et al.
Publicado: (2020)

Suspension laryngoscopy-assisted percutaneous dilatational tracheostomy: a safe method in COVID-19
por: Parmigiani, Franco, et al.
Publicado: (2021)

The vulnerability to COVID-19 of migrants in large urban areas: structural exacerbators and community-level mitigators
por: Hitch, Lisa, et al.
Publicado: (2023)

Clinical predictors for the prognosis of myasthenia gravis
por: Wang, Lili, et al.
Publicado: (2017)

Staying safe while staying together: the COVID‐19 paradox for participants returning to community‐based sport in Victoria, Australia
por: Staley, Kiera, et al.
Publicado: (2021)

Time-variant reproductive number of COVID-19 in Seoul, Korea
por: Moon, Seong-Geun, et al.
Publicado: (2020)

Letter to the Editor: Consideration of Neuroimmunological Diseases in Assessments of COVID-19 Vaccination Rates Among Patients With Chronic Medical Conditions
por: Kim, Sohyeon, et al.
Publicado: (2023)

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea
por: Kwon, Yunhyung, et al.
Publicado: (2022)

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
por: Noh, Yunha, et al.
Publicado: (2023)

Predictors of survival in older adults hospitalized with COVID-19
por: Tyson, Brad, et al.
Publicado: (2021)

A case of hemichorea following administration of the Pfizer-BioNTech COVID-19 vaccine
por: Ryu, Dong-Woo, et al.
Publicado: (2021)

Vaccine hesitancy due to vaccine country of origin, vaccine technology, and certification
por: Dror, Amiel A., et al.
Publicado: (2021)

Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform
por: Wing, Kevin, et al.
Publicado: (2022)

SG-APSIC1204: Time-based deisolation of generally asymptomatic immunocompetent COVID-19 patients on day 8 of infection to clean wards is safe
por: Fauzi, Nazira Binte Muhammad, et al.
Publicado: (2023)

Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States
por: Kim, Soyeoun, et al.
Publicado: (2022)

Effect of COVID-19 vaccination on transmission among healthcare workers in South Korea
por: Kim, Jiyun, et al.
Publicado: (2022)

Predictors of In-Hospital Mortality in Older Patients With COVID-19: The COVIDAge Study
por: Mendes, Aline, et al.
Publicado: (2020)

Predictors of “brain fog” 1 year after COVID-19 disease
por: Cristillo, Viviana, et al.
Publicado: (2022)

Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
por: Díez-Porras, Laura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kk9c3674cd8nc1i8kosj3ddtbl